TORRENT PHARMACEUTICALS LTD. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 25th January, 2023 at 05:30 P.M. to discuss the financial performance of the Company for the quarter and nine months ended 31st December, 2022.